上海医药2025年三大业务板块毛利率集体下滑遭问询 公司回复

南方财经网
Jul 27

南方财经7月27日电,上交所近日就上海医药(601607.SH)2025年年报下发监管问询函,重点关注公司主营业务三大板块毛利率集体下滑。问询函要求公司补充披露工业、分销、零售板块的产品结构、集采影响及同行业对比情况。数据显示,2025年公司医药工业营收245.22亿元,毛利率57.13%,同比下滑2.08个百分点;分销营收2588.28亿元,毛利率5.79%,微降0.15个百分点;零售营收...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10